Try our beta test site
1 study found for:    19287023 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: ABX-EGF (panitumumab)

Study has passed its completion date and status has not been verified in more than two years.